Animal wound healing and pain management product Tri-Solfen has been identified as the number one registration priority for Australia’s sheep, cattle, pig and alpaca industries.
The Australian Government Rural Industries and Research Development Corporation (RIRDC) revealed spray-on gel Tri-Solfen is an urgent priority in its recently published AgVet Technology Priority List, in a bid to address farm productivity issues caused by growing resistance to agricultural pesticides and veterinary (AgVet) chemicals.
Victoria-based Australian firm Animal Ethics, the developer of Tri-Solfen, said the product’s wound healing and pain relief technology addresses animal welfare concerns raised by welfare groups, retailers and consumers concerning painful livestock husbandry procedures, and improves animal welfare.
Tri-Solfen was initially developed to treat pain, bleeding and risk of infection associated with the mulesing procedure performed on lambs. Animal Ethics claims the technology has since proven highly effective in other husbandry procedures such as tail docking, castration, dehorning and accidental wounds. According to the firm, it therefore has the potential to reduce or eliminate the use of antibiotics traditionally used during these procedures.
Allan Giffard, managing director of Animal Ethics, said: “The result of the RIRDC forum in identifying Tri-Solfen as the number one priority for these major Australian industries, demonstrates a significant vote of confidence in the technology, and acknowledges the improved animal welfare outcomes that Tri-Solfen achieves.
“We are now working with these major livestock industry groups, and the Australian Regulator (APVMA), to ensure Tri-Solfen is approved as quickly as possible for use in other livestock during painful husbandry procedures”.
Outside of Australia, Animal Ethics has recently been granted patents for Tri-Solfen in the EU, US, Canada and New Zealand. In an interview with Animal Pharm in June, Mr Giffard explained the company was looking for a licensing partner to help develop the product’s regulatory requirements and aid commercialization in international markets. READ MORE